{
    "Trade/Device Name(s)": [
        "WaveSense Diabetes Manager",
        "WaveSense Diabetes Manager application",
        "WaveSense DiabetesManagement Application",
        "WaveSense BGM meters"
    ],
    "Submitter Information": "AgaMatrix, Inc.",
    "510(k) Number": "K101597",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062434"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "JQP"
    ],
    "Summary Letter Date": "September 22, 2010",
    "Summary Letter Received Date": "September 24, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Blood glucose"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "iPhone Operating System platform",
        "WaveSense-enabled Blood Glucose Meter (BGM)"
    ],
    "Method(s)/Technology(ies)": [
        "Digital logbook",
        "Data management software accessory"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Software",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for AgaMatrix WaveSense Diabetes Manager application as a digital logbook and data management accessory for blood glucose results using iPhone OS.",
    "Indications for Use Summary": "Intended for home and professional use to aid individuals with diabetes and healthcare professionals in review, analysis, and evaluation of blood glucose readings to support effective diabetes management.",
    "fda_folder": "Clinical Chemistry"
}